Martin Werle

1.5k total citations
24 papers, 1.1k citations indexed

About

Martin Werle is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Martin Werle has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 12 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Martin Werle's work include Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (9 papers) and RNA Interference and Gene Delivery (8 papers). Martin Werle is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (9 papers) and RNA Interference and Gene Delivery (8 papers). Martin Werle collaborates with scholars based in Austria, Japan and Germany. Martin Werle's co-authors include Hirofumi Takeuchi, Andreas Bernkop‐Schnürch, Martin Hoffer, Abdallah Makhlof, Yuichi Tozuka, Florian Föger, Krum Kafedjiiski, Brigitta Loretz, Harald Kolmar and Alexander Wentzel and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Martin Werle

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Werle Austria 16 697 432 376 194 83 24 1.1k
Vivek K. Pawar India 20 556 0.8× 339 0.8× 376 1.0× 97 0.5× 79 1.0× 39 1.5k
Glen Perera Austria 24 932 1.3× 415 1.0× 364 1.0× 57 0.3× 100 1.2× 32 1.4k
H.L. Lueßen Netherlands 9 1000 1.4× 340 0.8× 315 0.8× 57 0.3× 128 1.5× 10 1.3k
Supriya Shidhaye India 12 477 0.7× 306 0.7× 495 1.3× 58 0.3× 97 1.2× 29 1.2k
Florian Föger Austria 14 379 0.5× 192 0.4× 205 0.5× 112 0.6× 50 0.6× 17 662
Maite Agüeros Spain 17 497 0.7× 279 0.6× 471 1.3× 111 0.6× 74 0.9× 21 1.1k
Hiroyuki Yoshino Japan 15 452 0.6× 220 0.5× 308 0.8× 64 0.3× 52 0.6× 21 877
Omathanu Perumal United States 19 380 0.5× 542 1.3× 312 0.8× 81 0.4× 72 0.9× 29 1.4k
Juliane Hombach Austria 15 515 0.7× 155 0.4× 233 0.6× 79 0.4× 74 0.9× 17 759
Alaa Eldeen B. Yassin Saudi Arabia 19 618 0.9× 300 0.7× 276 0.7× 66 0.3× 74 0.9× 46 1.1k

Countries citing papers authored by Martin Werle

Since Specialization
Citations

This map shows the geographic impact of Martin Werle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Werle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Werle more than expected).

Fields of papers citing papers by Martin Werle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Werle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Werle. The network helps show where Martin Werle may publish in the future.

Co-authorship network of co-authors of Martin Werle

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Werle. A scholar is included among the top collaborators of Martin Werle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Werle. Martin Werle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werle, Martin & Florian Föger. (2017). Peroral peptide delivery: Peptidase inhibition as a key concept for commercial drug products. Bioorganic & Medicinal Chemistry. 26(10). 2906–2913. 7 indexed citations
2.
Makhlof, Abdallah, Martin Werle, Yuichi Tozuka, & Hirofumi Takeuchi. (2010). A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. Journal of Controlled Release. 149(1). 81–88. 102 indexed citations
3.
Makhlof, Abdallah, Martin Werle, Yuichi Tozuka, & Hirofumi Takeuchi. (2010). Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. International Journal of Pharmaceutics. 397(1-2). 92–95. 80 indexed citations
4.
Werle, Martin, Abdallah Makhlof, & Hirofumi Takeuchi. (2009). Oral Protein Delivery: A Patent Review of Academic and Industrial Approaches. Recent Patents on Drug Delivery & Formulation. 3(2). 94–104. 22 indexed citations
5.
Werle, Martin, Kohei Hironaka, Hirofumi Takeuchi, & Herbert Hoyer. (2008). Development and In Vitro Characterization of Liposomes Coated with Thiolated Poly(Acrylic Acid) for Oral Drug Delivery. Drug Development and Industrial Pharmacy. 35(2). 209–215. 18 indexed citations
6.
Werle, Martin, Hirofumi Takeuchi, & Andreas Bernkop‐Schnürch. (2008). Modified Chitosans for Oral Drug Delivery. Journal of Pharmaceutical Sciences. 98(5). 1643–1656. 88 indexed citations
7.
Werle, Martin, Hirofumi Takeuchi, & Andreas Bernkop‐Schnürch. (2008). New-generation efflux pump inhibitors. Expert Review of Clinical Pharmacology. 1(3). 429–440. 12 indexed citations
8.
Werle, Martin & Hirofumi Takeuchi. (2008). Chitosan–aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation. International Journal of Pharmaceutics. 370(1-2). 26–32. 83 indexed citations
9.
Föger, Florian, et al.. (2008). Effect of a thiolated polymer on oral paclitaxel absorption and tumor growth in rats. Journal of drug targeting. 16(2). 149–155. 13 indexed citations
10.
Werle, Martin. (2008). Liposomal Polyion-Complexes based on Poly(allylamine) for Oral Peptide Delivery: Basic Investigations. Scientia Pharmaceutica. 76(4). 751–760. 1 indexed citations
11.
Werle, Martin & Andreas Bernkop‐Schnürch. (2008). Thiolated chitosans: useful excipients for oral drug delivery. Journal of Pharmacy and Pharmacology. 60(3). 273–281. 59 indexed citations
12.
Kafedjiiski, Krum, Florian Föger, Herbert Hoyer, Andreas Bernkop‐Schnürch, & Martin Werle. (2007). Evaluation of In Vitro Enzymatic Degradation of Various Thiomers and Cross-Linked Thiomers. Drug Development and Industrial Pharmacy. 33(2). 199–208. 13 indexed citations
13.
Werle, Martin. (2007). Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps. Pharmaceutical Research. 25(3). 500–511. 160 indexed citations
14.
15.
Werle, Martin, Thierry Schmitz, Honglei Huang, et al.. (2006). The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery. Journal of drug targeting. 14(3). 137–146. 68 indexed citations
16.
Werle, Martin, et al.. (2006). Degradation of teriparatide by gastro-intestinal proteolytic enzymes. Journal of drug targeting. 14(3). 109–115. 23 indexed citations
17.
Loretz, Brigitta, Florian Föger, Martin Werle, & Andreas Bernkop‐Schnürch. (2006). Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion. Journal of drug targeting. 14(5). 311–319. 35 indexed citations
18.
Kafedjiiski, Krum, Martin Hoffer, Martin Werle, & Andreas Bernkop‐Schnürch. (2005). Improved synthesis and in vitro characterization of chitosan–thioethylamidine conjugate. Biomaterials. 27(1). 127–135. 49 indexed citations
19.
Kafedjiiski, Krum, Florian Föger, Martin Werle, & Andreas Bernkop‐Schnürch. (2005). Synthesis and in Vitro Evaluation of a Novel Chitosan–Glutathione Conjugate. Pharmaceutical Research. 22(9). 1480–1488. 88 indexed citations
20.
Werle, Martin & Martin Hoffer. (2005). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. Journal of Controlled Release. 111(1-2). 41–46. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek K. Pawar Breakdown of academic impact, for papers by Glen Perera Breakdown of academic impact, for papers by H.L. Lueßen Breakdown of academic impact, for papers by Supriya Shidhaye Breakdown of academic impact, for papers by Florian Föger Breakdown of academic impact, for papers by Maite Agüeros Breakdown of academic impact, for papers by Hiroyuki Yoshino Breakdown of academic impact, for papers by Omathanu Perumal Breakdown of academic impact, for papers by Juliane Hombach Breakdown of academic impact, for papers by Alaa Eldeen B. Yassin
Rankless by CCL
2026